New Leukemia Drug Works When Standard Treatments Fail

Scientists at MD Anderson Cancer Center discovered an experimental therapy that stops aggressive leukemia cells even after they've become resistant to standard treatments.

The breakthrough could help patients with the deadliest forms of blood cancer who have run out of options.